Article Details
Retrieved on: 2021-04-04 02:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The biotechnology company reported $0.12 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.06) by $0.18.
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here